Uganda

This project improves sustainable ART service delivery for children and confronts challenges that adolescents face around disclosure, adherence, and psychosocial support.

In 2022, the NH will transition to a new phase of New Horizons 2.0, EGPAF as a key implementing partner along with other current partners including Partnership for Supply Chain Management, Imperial Logistics, CIPHER Paediatric HIV Matters, Right to Care, and the Paediatric European Network for Treatment of AIDS.

This DNDi-supported project will streamline and accelerate use of new, child- friendly ART formulations. EGPAF will focus on the development of new tools for improved control of pediatric HIV and support increased uptake of solid lopinavir/ ritonavir, while preparing for introduction of dispersible dolutegravir formulations in Kenya, Tanzania and Uganda.

In 2021, the NH will transition to a new phase of New Horizons 2.0, EGPAF as a key implementing partner along with other current partners including Partnership for Supply Chain Management, Imperial Logistics, CIPHER Paediatric HIV Matters, Right to Care, and the Paediatric European Network for Treatment of AIDS.

With funding from Johnson & Johnson and in partnership with the Uganda MOH, EGPAF provides technical assistance on pediatric second- and third-line ART access. This project, which will run in Uganda from 2018 to 2020, aims to improve sustainable ART service delivery for children, and confront challenges faced by adolescents around disclosure, adherence, and psychosocial support. The heart of the Collaborative is a darunavir/etravirine donation program, which increases availability of third-line pediatric and adult ART for children and adolescents failing second-line treatment.

This DNDi-supported project will streamline and accelerate use of new, child- friendly ART formulations. EGPAF will focus on the development of new tools for improved control of pediatric HIV and support increased uptake of solid lopinavir/ritonavir, while preparing for introduction of dispersible dolutegravir formulations in Kenya, Tanzania and Uganda.

DELTA is currently implementing three assignments in Uganda, with U.S. Centers for Disease Control and Prevention (CDC) funding. The first centers on development of a pediatric and adolescent HIV testing and counselling eligibility screening tool.

This United States Agency for International Development (USAID)-funded study examines different service delivery strategies for actively finding HIV-positive children to determine levels of success with diagnosis, linkage to care and treatment initiation in Uganda.

With funding from ELMA Foundation, EGPAF-Uganda is working to improve pediatric and adolescent HIV identification, linkage, and retention into care and treatment in seven districts of southwest Uganda.

Through the Saving Lives at Birth Initiative, EGPAF, the Ugandan Ministry of Health and Pratt Pouch Consulting, through USAID funding, will introduce and scale-up the Pratt Pouch in antenatal care, delivery, and post-natal care facilities throughout the country.